Cytosorbents Corp
CTSO
31 hedge funds and large institutions have $8.34M invested in Cytosorbents Corp in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 9 closing their positions.
2.72% less ownership
Funds ownership: 9.62% → 6.9% (-2.7%)
16% less funds holding
Funds holding: 37 → 31 (-6)
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
58% less capital inflows, than outflows
Capital inflows: $1.66M | Capital outflows: $3.96M
58% less call options, than puts
Call options by funds: $146K | Put options by funds: $350K
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Skylands Capital
Milwaukee,
Wisconsin
|
+$1.22M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$160K |
| 3 |
Raymond James & Associates
St Petersburg,
Florida
|
+$108K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$98.6K |
| 5 |
Private Advisor Group
Morristown,
New Jersey
|
+$43.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Advisor Group
Phoenix,
Arizona
|
-$1.21M |
| 2 |
Millennium Management
New York
|
-$780K |
| 3 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$698K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$504K |
| 5 |
Cowen Inc
New York
|
-$248K |
CTSO Hedge Fund Activity: Q2 2017 in Review
31 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q2 2017, worth a combined $8.34M — down 25% from $11.1M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CTSO and 3 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 8 added.
The largest buyer was Skylands Capital, adding an estimated $1.22M. The largest seller was Advisor Group, cutting an estimated $1.21M.
- 31 institutional investors held Cytosorbents Corp (CTSO) as of Q2 2017, down from 37 in Q1 2017.
- Funds reported $8.34M of Cytosorbents Corp stock for Q2 2017, down 25% quarter-over-quarter.
- 3 funds opened new Cytosorbents Corp positions in Q2 2017 and 9 closed out, a net change of -6 holders.
- The largest Cytosorbents Corp buyer in Q2 2017 was Skylands Capital, an estimated $1.22M added.
- The largest Cytosorbents Corp seller in Q2 2017 was Advisor Group, an estimated $1.21M sold.
Based on aggregated 13F filings for Q2 2017.